Concepedia

Author

Orsolya Rusz

University of SzegedORCID

Also Known As

O. Rusz, ORSOLYA RUSZ, Orsolya Rusz, R. Orsolya, Rusz, Orsolya

75

Publications

540

Citations

11

H-Index

16

Concepts

All Affiliations

University of SzegedDanish Cancer SocietySemmelweis UniversityBács-Kiskun Megyei KórházHungarian Academy of Sciences
OR

About

Orsolya Rusz is an author at University of Szeged specializing in radiation oncology, medicine, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

51

2

Health Sciences

1

1

21

3

Endocrinology

1

1

11

4

Immunology

1

1

11

5

Obstetrics

1

1

11

Orsolya Rusz

×

11

Publications

448

Citations

10

H-Index

YearCitations

Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents

Ádám Póti, Hella Gyergyák, Eszter Németh,

Genome biology

2019

118

Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations

Zsófia Sztupinszki, Miklós Dióssy, Judit Börcsök,

Clinical Cancer Research

2020

111

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors

Miklós Dióssy, Lilla Reiniger, Zsófia Sztupinszki,

Annals of Oncology

2018

74

Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer

Judit Börcsök, Miklós Dióssy, Zsófia Sztupinszki,

Clinical Cancer Research

2021

24

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

Miklós Dióssy, Zsófia Sztupinszki, Judit Börcsök,

npj Precision Oncology

2021

24

Different Methods of Pretreatment Ki-67 Labeling Index Evaluation in Core Biopsies of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Their Relation to Response to Therapy

András Vörös, Erika Csörgő, Bence Kővári,

Pathology & Oncology Research

2014

21

One-Year Neoadjuvant Endocrine Therapy in Breast Cancer

Orsolya Rusz, András Vörös, Zoltán Varga,

Pathology & Oncology Research

2015

19

Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series

Orsolya Rusz, Renáta Kószó, Ágnes Dobi,

OncoTargets and Therapy

2018

18

Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy

Edit Magdolna Biró, Zsuzsanna Kahán, János Kálmán,

In Vivo

2019

18

Differential immunostaining of various types of breast carcinomas for growth hormone‐releasing hormone receptor – Apocrine epithelium and carcinomas emerging as uniformly positive

Bence Kővári, Orsolya Rusz, Andrew V. Schally,

Apmis

2014

11

Page 1